AMGN:NGS-Amgen Inc.

EQUITY | Drug Manufacturers | Nasdaq Global Select

Last Closing

USD 191.49

Change

+0.18 (+0.09)%

Market Cap

USD 107.37B

Volume

2.27M

Analyst Target

USD 204.38
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Amgen Inc is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. The Company's business segment is human therapeutics.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-03-19 )

Largest Industry Peers for Drug Manufacturers

ETFs Containing AMGN

BTEC:SW iShares Nasdaq US Biotech.. 8.25 % 0.00 %

-0.03 (0.10%)

USD 0.46B
2B70:F iShares NASDAQ US Biotech.. 8.24 % 0.00 %

-0.05 (0.10%)

USD 0.52B
2B70:XETRA iShares Nasdaq US Biotech.. 8.24 % 0.00 %

-0.05 (0.10%)

USD 0.52B
UBIO 6.41 % 0.95 %

N/A

N/A
LIFE-U:CA Evolve Global Healthcare .. 5.97 % 0.00 %

N/A

N/A
MEDX Horizon Kinetics Medical .. 5.28 % 0.00 %

-0.05 (0.10%)

USD 0.75B
NDJI 4.95 % 0.00 %

N/A

N/A
ZWHC:CA BMO Covered Call Health C.. 4.94 % 0.00 %

-0.12 (0.10%)

CAD 0.01B
EXI3:F iShares Dow Jones Industr.. 4.66 % 0.00 %

-0.45 (0.10%)

USD 0.29B
EXI3:XETRA iShares Dow Jones Industr.. 4.66 % 0.00 %

+2.85 (+0.10%)

USD 0.30B
CSINDU:SW iShares VII PLC - iShares.. 4.66 % 0.00 %

+0.40 (+0.10%)

USD 1.16B
1546:TSE NEXT FUNDS DJIA (Yen-UnHe.. 4.63 % 0.00 %

-90.00 (0.10%)

USD 19.52B
SXRU:XETRA iShares Dow Jones Indust .. 4.61 % 0.00 %

+3.20 (+0.10%)

USD 1.16B
CIND:LSE iShares VII PLC - iShares.. 4.60 % 0.00 %

+4.49 (+0.10%)

USD 1.14B
DJIA Global X Dow 30 Covered C.. 4.58 % 0.00 %

-0.07 (0.10%)

USD 0.08B
DIA SPDR Dow Jones Industrial.. 4.55 % 0.17 %

+0.39 (+0.10%)

USD 33.55B
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.20 % 0.00 %

-0.07 (0.10%)

USD 0.15B
GDOC Goldman Sachs ETF Trust 3.43 % 0.00 %

-0.24 (0.10%)

USD 0.03B
WH2E:XETRA Invesco Markets II plc - .. 3.35 % 0.00 %

+0.03 (+0.10%)

USD 2.31M
FDV First Trust Capital Stren.. 3.21 % 0.00 %

+0.11 (+0.10%)

USD 0.09B
DDM ProShares Ultra Dow30 3.21 % 0.95 %

+0.11 (+0.10%)

USD 0.41B
ESGI:AU VanEck MSCI International.. 3.09 % 0.00 %

N/A

USD 0.19B
HEAL:CA 2.96 % 0.00 %

N/A

N/A
NZRO 2.90 % 0.00 %

N/A

N/A
ZPDH:F SPDR S&P U.S. Health Care.. 2.78 % 0.00 %

-0.03 (0.10%)

USD 0.40B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 2.78 % 0.00 %

+0.09 (+0.10%)

USD 0.40B
GXLV:LSE SPDR® S&P® U.S. Health .. 2.78 % 0.00 %

+0.09 (+0.10%)

USD 0.39B
QDVG:F iShares S&P 500 Health Ca.. 2.77 % 0.00 %

-0.01 (0.10%)

USD 2.09B
QDVG:XETRA iShares S&P 500 Health Ca.. 2.77 % 0.00 %

+0.02 (+0.10%)

USD 2.05B
IUHC:LSE iShares S&P 500 USD Healt.. 2.75 % 0.00 %

+0.03 (+0.10%)

USD 2.07B
IUHC:SW iShares S&P 500 Health Ca.. 2.73 % 0.00 %

-0.03 (0.10%)

USD 2.07B
SXLV:SW SPDR S&P U.S. Health Care.. 2.72 % 0.00 %

+0.15 (+0.10%)

N/A
XUHC:F Xtrackers (IE) Public Lim.. 2.71 % 0.00 %

-0.08 (0.10%)

USD 0.85B
XUHC:XETRA Xtrackers MSCI USA Health.. 2.71 % 0.00 %

+0.10 (+0.10%)

USD 0.85B
XUHC:SW Xtrackers MSCI USA Health.. 2.65 % 0.00 %

-0.25 (0.10%)

USD 0.81B
XSHC:LSE Xtrackers MSCI USA Health.. 2.64 % 0.00 %

+10.50 (+0.10%)

USD 1.04B
XUHC:LSE Xtrackers MSCI USA Health.. 2.64 % 0.00 %

+0.26 (+0.10%)

USD 1.04B
UDOW ProShares UltraPro Dow30 2.47 % 0.95 %

+0.14 (+0.10%)

USD 0.59B
UVDV 2.35 % 0.00 %

N/A

N/A
HLTH:AU VanEck Global Healthcare .. 2.08 % 0.00 %

N/A

USD 0.06B
WEBD:XETRA AETF-MUSCNZAP EOA ETF 2.00 % 0.00 %

+0.10 (+0.10%)

N/A
CURE Direxion Daily Healthcare.. 1.98 % 1.06 %

-0.39 (0.10%)

USD 0.21B
USRI:LSE 1.80 % 0.00 %

N/A

N/A
2B78:XETRA iShares Healthcare Innova.. 1.68 % 0.00 %

-0.04 (0.10%)

USD 1.14B
HEAL:SW iShares Healthcare Innova.. 1.65 % 0.00 %

-0.03 (0.10%)

N/A
ZDY.U:CA 1.63 % 0.33 %

N/A

N/A
RSPH Invesco S&P 500® Equal.. 1.61 % 0.00 %

-0.08 (0.10%)

USD 1.02B
LESW:LSE 1.25 % 0.00 %

N/A

N/A
TQGD:CA TD Q Global Dividend ETF 1.16 % 0.00 %

-0.03 (0.10%)

CAD 0.19B
XAMB:F Amundi Index Solutions - .. 1.14 % 0.00 %

+0.13 (+0.10%)

N/A
UEFY:XETRA UBS - SBI Foreign AAA-BBB.. 1.09 % 0.00 %

N/A

USD 0.45B
SF1CHA:SW 1.09 % 0.00 %

N/A

N/A
F1ESG:SW UBS(Lux)Fund Solutions .. 1.09 % 0.00 %

+0.02 (+0.10%)

USD 0.39B
CURE:AU ETFS S&P Biotech ETF 1.06 % 0.00 %

N/A

USD 0.04B
BBH VanEck Biotech ETF 0.00 % 0.35 %

-1.02 (0.10%)

USD 0.45B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

-0.94 (0.10%)

USD 0.10B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

+0.41 (+0.10%)

USD 3.90M
DJD Invesco Dow Jones Industr.. 0.00 % 0.09 %

+0.10 (+0.10%)

USD 0.32B
FHLC Fidelity® MSCI Health Ca.. 0.00 % 0.08 %

-0.05 (0.10%)

USD 3.19B
IBB iShares Biotechnology ETF 0.00 % 0.47 %

-1.25 (0.10%)

USD 7.79B
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

-0.01 (0.10%)

USD 3.48B
LABS 0.00 % 0.45 %

N/A

N/A
LNGR 0.00 % 0.50 %

N/A

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

-0.94 (0.10%)

USD 0.24B
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

-0.48 (0.10%)

USD 0.29B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

-0.04 (0.10%)

USD 0.02B
HONR 0.00 % 0.65 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
SDG iShares MSCI Global Impac.. 0.00 % 0.49 %

+0.49 (+0.10%)

USD 0.30B
DURA 0.00 % 0.00 %

N/A

N/A
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.04 (0.10%)

USD 0.49B
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.04 (0.10%)

USD 0.49B
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.04 (0.10%)

USD 0.49B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

+0.01 (+0.10%)

USD 1.09M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.01 (+0.10%)

USD 1.09M
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

-0.16 (0.10%)

USD 0.09B
SCHD Schwab U.S. Dividend Equi.. 0.00 % 0.07 %

N/A

USD 64.32B
SICK 0.00 % 0.95 %

N/A

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

-0.30 (0.10%)

USD 17.89B
XLV Health Care Select Sector.. 0.00 % 0.13 %

-0.01 (0.10%)

USD 40.87B
ZBIO 0.00 % 0.95 %

N/A

N/A
ZDJ:CA BMO Dow Jones Industrial .. 0.00 % 0.26 %

+0.04 (+0.10%)

CAD 0.39B
ZUH:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

-0.47 (0.10%)

CAD 0.32B
ZWA:CA BMO Covered Call Dow Jone.. 0.00 % 0.72 %

-0.06 (0.10%)

CAD 0.21B
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

-1.00 (0.10%)

USD 1.14B
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

-0.04 (0.10%)

USD 1.14B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+2.25 (+0.10%)

USD 1.69B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.15 (+0.10%)

USD 0.40B
VMVL:LSE 0.00 % 0.00 %

N/A

N/A
WQDS:LSE iShares MSCI World Qualit.. 0.00 % 0.00 %

+0.75 (+0.10%)

USD 0.81B
WQDV:LSE iShares MSCI World Qualit.. 0.00 % 0.00 %

+0.02 (+0.10%)

USD 0.81B
XLDX:LSE Xtrackers LevDAX Daily Sw.. 0.00 % 0.00 %

+118.00 (+0.10%)

USD 0.04B
XMAD:LSE Xtrackers - MSCI EM Asia .. 0.00 % 0.00 %

+0.50 (+0.10%)

USD 0.41B
XMAS:LSE Xtrackers MSCI EM Asia ES.. 0.00 % 0.00 %

+35.50 (+0.10%)

USD 0.24B
GNAR:F 0.00 % 0.00 %

N/A

N/A
MJMT:F Amundi Index Solutions - .. 0.00 % 0.00 %

-0.14 (0.10%)

USD 0.06B
SXRU:F iShares Dow Jones Indust .. 0.00 % 0.00 %

-0.45 (0.10%)

USD 1.12B
GNAR:XETRA 0.00 % 0.00 %

N/A

N/A
VMVL:XETRA 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
ESNG 0.00 % 0.00 %

N/A

N/A
BMED BlackRock Future Health E.. 0.00 % 0.00 %

-0.21 (0.10%)

USD 4.14M
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

-0.23 (0.10%)

USD 0.03B
WELG:XETRA Amundi S&P Global Health .. 0.00 % 0.00 %

+0.04 (+0.10%)

USD 0.24B
WELS:XETRA Amundi S&P Global Health .. 0.00 % 0.00 %

+0.02 (+0.10%)

USD 0.24B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.63% 17% F 17% F
Dividend Return 0.74% 67% D+ 55% F
Total Return -0.89% 18% F 17% F
Trailing 12 Months  
Capital Gain 4.90% 61% D- 71% C-
Dividend Return 2.96% 80% B- 71% C-
Total Return 7.86% 64% D 72% C
Trailing 5 Years  
Capital Gain 51.28% 80% B- 69% C-
Dividend Return 16.05% 100% F 69% C-
Total Return 67.33% 84% B 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.22% 64% D 59% D-
Dividend Return 11.78% 69% C- 61% D-
Total Return 2.57% 86% B+ 65% D
Risk Return Profile  
Volatility (Standard Deviation) 13.63% 99% N/A 79% B-
Risk Adjusted Return 86.44% 99% N/A 83% B
Market Capitalization 107.37B 100% F 100% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 15.10 14% 31%
Price/Book Ratio 8.50 22% 12%
Price / Cash Flow Ratio 2.85 16% 34%
Price/Free Cash Flow Ratio 11.70 15% 36%
Management Effectiveness  
Return on Equity 58.52% 92% 95%
Return on Invested Capital 22.83% 99% 88%
Return on Assets 12.32% 93% 91%
Debt to Equity Ratio 242.50% 14% 8%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector